Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
- Posted on July 21, 2026
- By CNBC
- 0 Views
- 1 min read
In brief
Generating AI summary…
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo asked the court to permanently stop Lilly from running the "deceptive" ads and require the drugmaker to issue corrective advertising.